About Magna Labs
Magna Labs is a Healthcare company based in Falls Church (United States) founded in 2020 by Gwenn Berry. Automated quality assurance for bioinformatics software is specialized in. Magna Labs has raised $150 thousand across 1 funding round from investors including Merck Digital Sciences Studio. Its chief executive, as recorded, is Gwenn Berry. Magna Labs offers products and services including Miqa QA Platform and Data Management Services. Its focus areas include Medical Research Labs.
Company details
Magna Labs was founded in 2020 and is based in Falls Church, United States. Operations center on software development within the bioinformatics sector. Automated quality assurance tools and solutions are provided to support the construction of bioinformatics software, emphasizing speed, safety, and validated standards. Services are tailored for developers seeking reliable testing frameworks in this field.
- Headquarters Falls Church, United States
- Founders Gwenn Berry
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website magnalabs.co
- Social LinkedIn X
- Legal Name Magna Labs
- Annual Revenue$604.68 K (USD)480as on Dec 31, 2023
- Net Profit$1.63 M (USD)236as on Dec 31, 2024
- EBITDA-$1.56 M (USD)-53as on Dec 31, 2024
- Total Equity Funding$150K (USD)
in 1 rounds
- Latest Funding Round$150K (USD), Seed
Jan 2023
- Investors
Products & Services of Magna Labs
Magna Labs offers a comprehensive portfolio of products and services, including Miqa QA Platform and Data Management Services.
QA automation for bioinformatics is provided, including continuous testing, validation, and workflow integration to ensure accuracy in computational biology.
Centralized management of testing data and results is offered, facilitating upload, simulation, curation, and interactive reporting for bioinformatic projects.
Funding Insights of Magna Labs
Magna Labs has successfully raised a total of $150K through 1 strategic funding round. The most recent funding activity was a Seed round of $150 thousand completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $150,000
- Total Rounds 1
- Last Round Seed — $150,000
- First Round $150,000
(Jan 2023)
- Investors Count 1
All 1 funding rounds of Magna Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $150,000 | Seed | – | MDS Studio | – |
1 investors in total: 1 institutional.
Investors in Magna Labs
Magna Labs has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Merck Digital Sciences Studio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
An accelerator program for digital health startups is operated. | mds.studio | Rahway, USA |
Investor details for Magna Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Magna Labs
1 people are tracked at Magna Labs (1 in leadership).
| Name | Role | Group |
|---|---|---|
Gwenn Berry | Founder & CEO | Leadership |
Complete people profiles for Magna Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Magna Labs
2 dated milestones of Magna Labs across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Magna Labs is founded.
- Funding First funding round of $150K.
Top companies in Clinical Trials & Research Tech
3 companies that operate in the same segment as Magna Labs (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 619.8 M | 252 | ||
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | 22 | ||
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | 25 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Magna Labs
Magna Labs was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Magna Labs is headquartered in Falls Church, United States. It is registered at Falls Church, Virginia, United States.
Gwenn Berry is the CEO of Magna Labs, as recorded in our data. They have also founded this company.
Magna Labs is a funded company, having raised a total of $150K across 1 funding round to date. The company's 1st funding round was a Seed of $150K, raised on Jan 2023.
Annual revenue of Magna Labs is $604.68K as on Dec 31, 2023.
Magna Labs was founded in 2020 and is based in Falls Church, United States. Operations center on software development within the bioinformatics sector. Automated quality assurance tools and solutions are provided to support the construction of bioinformatics software, emphasizing speed, safety, and validated standards. Services are tailored for developers seeking reliable testing frameworks in this field.
Magna Labs offers Miqa QA Platform and Data Management Services.
Magna Labs has 1 investor. Key investors include Merck Digital Sciences Studio.
Magna Labs operates through Magna Labs.